Physician profile
Christopher Halpin
NPI 1326284787
$3,022.59
in general payments reported to CMS, 2019-2025
24 companies · $309 in 2025
The $309 reported for 2025 was less than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $291 · 2020: $136 · 2021: $85.91 · 2022: $155 · 2023: $381 · 2024: $1,666 · 2025: $309.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,360 · Travel and Lodging: $996.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,360.32 |
| Travel and Lodging | $995.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,078.01 | 2024 | |
| Glaxosmithkline, LLC. | $338.96 | 2019-2025 | Trelegy Ellipta, Nucala |
| Boehringer Ingelheim Pharmaceuticals, INC. | $313.94 | 2019-2025 | Ofev, Stiolto Respimat, Spiriva Respimat |
| Harmony Biosciences LLC | $250.96 | 2022-2025 | Wakix |
| Astrazeneca Pharmaceuticals Lp | $203.84 | 2019-2025 | Airsupra, Fasenra, Tezspire |
| Jazz Pharmaceuticals INC. | $178.30 | 2022-2024 | |
| Abbvie INC. | $111.69 | 2023 | |
| Philips North America LLC | $57.57 | 2023-2025 | Vest Therapy Und, (Ak6) Vest Therapy |
| Amgen INC. | $56.42 | 2022-2024 | Tezspire |
| Verona Pharma, INC. | $53.44 | 2025 | Ohtuvayre |
| Inspire Medical Systems, INC. | $46.66 | 2025 | Inspire |
| Ani Pharmaceuticals, INC. | $36.12 | 2024 | Purified Cortrophin Gel |
| Boston Scientific Corporation | $35.28 | 2021 | |
| Merck Sharp & Dohme LLC | $35.23 | 2021-2023 | |
| Tactile Systems Technology INC | $32.79 | 2023 | Entre Plus, Flexitouch Plus |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Electromed, INC. | $27.03 | 2025 | Smartvest |
| Takeda Pharmaceuticals U.S.A., INC. | $26.98 | 2024 | Aralast |
| Lilly USA, LLC | $22.32 | 2025 | Zepbound |
| Cardinal Health 200 LLC | $22.00 | 2024 | |
| Resmed Corp | $20.95 | 2023 | |
| Inari Medical, INC. | $20.78 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Mylan Specialty L.P. | $20.50 | 2019 | |
| Pinnacle Biologics, INC | $18.28 | 2019 | |
| Advanced Respiratory, INC | $14.54 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Halpin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.